BioHealth News Archive
USM looking for a new Director for the Institute for Bioscience and Biotechnology Research
IBBR (www.ibbr.umd.edu) is a joint research institute, which brings together partner institutions including the University of Maryland, College Park (UMCP); University of Maryland, Baltimore…
Read MoreGSK ranked first among global pharmaceuticals
GlaxoSmithKline (GSK) has been ranked first among global pharmaceuticals companies assessed for their efforts to improve access to medicine in developing countries, in the…
Read MoreSmall Business Administration Final SBIR Rules
On December 27, 2012, the US Small Business Administration (SBA) published a final rule to amend regulations governing eligibility for the Small Business Innovation…
Read MoreFreeman A. Hrabowski III, UMBC president, joins T. Rowe Price board – baltimoresun.com
Freeman A. Hrabowski III, president of the University of Maryland, Baltimore County, has joined the board of T. Rowe Price Group as an independent…
Read MoreMan meets machine at Johns Hopkins – Healthcare IT News
"Disease is too complex to just think your way through it," says Raimond Winslow, director of The Institute for Computational Medicine at Johns Hopkins.…
Read MoreEmergent Biosolutions (EBS) Acquires Commercial Rights To Pandemic Influenza Vaccine Candidate – iStockAnalyst.com
Emergent Biosolutions Inc. said it has secured exclusive right to manufacture and sell VaxInnate Corp.'s pandemic influenza vaccine candidate in the United States. Under a…
Read MoreCommentary: How Maryland can pull a tech trifecta in 2013 – The Washington Post
Maryland policymakers have taken encouraging steps the past two years to strengthen the state’s technology and life sciences economy. Two years ago, they expanded…
Read MoreMicroscopic Battlefield: Watch as a Killer T Cell Attacks a Cancer Cell – Open Culture
Every day, inside our body, there is a war going on. Microscopic invaders of one kind or another try to make a meal of…
Read MoreEmergent BioSolutions Secures Exclusive U.S. Commercial Rights to Next Generation Pandemic Influenza – DailyFinance
Emergent BioSolutions Inc. (NYS: EBS) announced today that it has signed a license agreement with VaxInnate Corporation under which Emergent acquired the exclusive right…
Read MoreSBIR changes taking effect in January – BioCentury.com
The U.S. Small Business Association (SBA) published a final rule on Thursday that will implement changes to the Small Business Innovation Research (SBIR) program,…
Read MoreJohns Hopkins receives funding for cholera vaccine initiative
The Johns Hopkins Bloomberg School of Public Health was awarded a four-year, $5 million grant from the Bill & Melinda Gates Foundation to promote…
Read MoreCytImmune and AstraZeneca to Research Potential New Nanomedicine – FierceBiotech
CytImmune and AstraZeneca have entered into an agreement to study the feasibility of a new cancer nanomedicine that will bind an oncology compound from…
Read MoreAstraZeneca’s Waltham unit aims to use gold nanoparticles to deliver cancer drugs directly to tumors – The Boston Globe
The pharmaceutical giant AstraZeneca is expected to announce this week that its oncology unit in Waltham is collaborating with a Maryland company to develop…
Read MoreNew Atlantic Ventures launches new VC fund – Washington Business Journal
Reston-based New Atlantic Ventures, which invests in technology start-ups, has launched its fourth venture capital fund. The New Atlantic Venture Fund IV expects to…
Read MoreThree Tensions In Medical Innovation To Watch For In 2013 – Forbes
As we anticipate a new year characterized by unprecedented interest in healthcare innovation, pay particular attention to the following three emerging tensions in the…
Read More